The Centers for Disease Control and Prevention National Institute for Occupational Safety and Health (NIOSH) has published final versions of two documents: Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings and Managing Hazardous Drug Exposures: Information for Healthcare Settings.
Published as draft guidance in 2020, the finalized procedures document creates a new two-table format to develop the NIOSH list. The new list format will allow organizations more flexibility for certain drugs when implementing USP General Chapter <800> Hazardous Drugs--Handling in Healthcare Settings. ASHP submitted comments in response to the 2020 draft documents in support of this new format.
The NIOSH List of Hazardous Drugs in Healthcare Settings, 2023 will appear in a future Federal Register notice. Until then, the 2016 list is still the most recent final document with a listing of hazardous drugs in healthcare settings.
Recent Articles
Pharmacy Colleagues Remember Robert Lantos, ASHP's 30th President
April 25, 2024
Enormous Demand for Weight-Loss Drugs Drives Up Total U.S. Prescription Spending
April 24, 2024
